Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3β) and Alzheimer's disease risk

Acta Neurologica Scandinavica

Volumn 120, Issue 2, 2009, Pages 130-133

  Mateo, I ^a   Vazquez Higuera J L ^a   Sanchez Juan P ^a   Rodriguez Rodriguez E ^a   Infante, J ^a   Garcia Gorostiaga I ^a   Berciano, J ^a   Combarros, O ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Alzheimer's disease; Cyclin dependent kinase 5 regulatory subunit 1; Epistasis; Gene polymorphism; Glycogen synthase kinase 3

Indexed keywords

CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 5 REGULATORY SUBUNIT 1; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EPISTASIS; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN PHOSPHORYLATION; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE 5; EPISTASIS, GENETIC; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTEIN SUBUNITS; RISK FACTORS; TAU PROTEINS;

EID: 67651235921     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01128.x     Document Type: Article

References (19)

1. Wang JZ, Grundke-Iqbal I, Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 2007 25 : 59 68.
2. Flaherty DB, Soria JP, Tomasiewicz HG, Wood JG. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3β and cdk5 are key participants. J Neurosci Res 2000 62 : 463 72.
3. Ferrer I, Barrachina M, Puig B. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol 2002 104 : 583 91.
4. Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 1997 56 : 70 8.
5. Pei JJ, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages od Alzheimer's disease neurofibrillary degeneration. Brain Res 1998 797 : 267 77.
6. Leroy K, Yilmaz Z, Brion JP. Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 2007 33 : 43 55.
7. Sengupta A, Wu Q, Grundke-Iqbal I, Iqbal K, Singh TJ. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Mol Cell Biochem 1997 167 : 99 105.
8. Li T, Hawkes C, Qureshi HY, Kar S, Paudel HK. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β. Biochemistry 2006 45 : 3134 45.
9. Patrick GN, Zukerberg L, Nikolic M, De Lamonte S, Dikkes P, Tsai LH. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999 402 : 615 22.
10. Tseng HC, Zhou Y, Shen Y, Tsai LH. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett 2002 523 : 58 62.
11. Venturin M, Moncini S, Villa V et al. Mutations and novel polymorphisms in coding regions and UTRs of CDK5R1 and OMG genes in patients with non-syndromic mental retardation. Neurogenetics 2006 7 : 59 66.
12. Moncini S, Bevilacqua A, Venturin M et al. The 3′ untranslated region of human Cyclin-Dependent Kinase 5 Regulatory subunit I contains regulatory elements affecting transcript stability. BMC Mol Biol 2007 8 : 111.
13. Mateo I, Infante J, Llorca J, Rodriguez E, Berciano J, Combarros O. Association between glycogen syntase kinase-3β genetic polymorphism and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord 2006 21 : 228 32.
14. Mckhaan G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDA-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984 34 : 934 44.
15. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000 405 : 360 4.
16. Rademakers R, Sleegers K, Theuns J et al. Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's disease. Neurobiol Aging 2005 26 : 1145 51.
17. Arias-Vasquez A, Aulchenko YS, Isaacs A et al. Cyclin-dependent kinase 5 is associated with risk for Alzheimer's disease in a Dutch population-based study. J Neurol 2008 255 : 655 62 doi :).
18. Kwok JB, Hallupp M, Loy CT et al. GSK3B poymorphisms alter transcription and splicing in Parkinson's disease. Ann Neurol 2005 58 : 829 39.
19. Combarros O, Cortina-Borja M, Smith AD, Lehmann DJ. Epistasis in sporadic Alzheimer's disease. Neurobiol Aging 2008 doi : Epub ahead of print).